Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
ABX 51.81 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.82 +9.7% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.81 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.82 +9.7% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%
Earnings Routine +

Mercanto Holdings Inc. Reports Q2 2026 Financial Results and Provides Commercial Update on Quebec Product Launches

Mercanto Delivers On Profitability Guidance As Quebec Vape Push Stabilizes, Eyes Summer Pipeline Rollout

By The Northwire Desk — AI Analysis Mar 25, 2026 · 09:02 MUSH · 0.135 Mercanto Holdings Inc.
Executive Summary
  • Mercanto reported Q2 FY2026 revenue of $2.08 million, representing a 107% year-over-year increase, directly aligning with the $2.05-$2.20 million guidance issued on February 24, 2026.
  • The company achieved positive EBITDA of $252,233 and net income of $177,785, successfully reversing prior-year losses and landing within management's projected ranges.
  • Commercial updates highlight a June 2026 launch for an infused pre-roll and an August 2026 launch for a 10 mg CBD capsule, expanding the Quebec CBD capsule portfolio to four SKUs.
  • The balance sheet confirms no long-term debt aside from lease liabilities, with 51,674,683 common shares outstanding and full compliance with all cannabis excise tax obligations.
Material Impact
  • Financial results precisely match the forward-looking guidance provided one month prior, confirming disciplined execution rather than delivering a market surprise.
  • The transition to quarterly profitability is a meaningful operational milestone for a micro-cap operator, but it was explicitly guided and therefore already factored into the recent $0.14-$0.17 trading range.
  • The upcoming product launches represent standard pipeline expansion and incremental revenue diversification rather than transformative catalysts.
  • No unexpected dilution, regulatory setbacks, or supply chain disruptions were disclosed, validating management's operational narrative and reducing near-term downside risk.
MUSH · Price
Company Overview
  • Mercanto Holdings is a Quebec-focused cannabis and CBD company operating exclusively within the provincial SQDC distribution framework.
  • Flagship products include a diversified CBD capsule portfolio (50 mg, 100 mg, and upcoming 10 mg/25 mg SKUs) and a newly launched vape cartridge line (Afghan Gold, Cherry Blossom, Peach Sumo) paired with the CCELL-manufactured M3BPlus battery.
  • The corporate strategy centers on capturing regulated market share through targeted product formats, leveraging recent Quebec regulatory improvements that guarantee minimum one-year in-store listings for approved categories.
Read the original news release →

More from Mercanto Holdings Inc.

Jun 25, 2026 · 09:03

Quebec vape inventory reset drives sequential revenue dip; profitability holds but growth narrative stalls.

Earnings Mar 25, 2026 · 18:30

Mercanto Holdings earns $177,785 in Q2

Earnings Feb 24, 2026 · 19:28

Mercanto estimates $150,000 profit for Q2

Earnings Feb 24, 2026 · 09:13

Mercanto Provides Forward-Looking Operational Update on Q2 2026 Performance and Portfolio Trends

Production / Operations Dec 29, 2025 · 17:10

Mercanto Holdings loses $146,213 in fiscal Q1 2026

Earnings Dec 29, 2025 · 13:42

Mercanto Holdings Inc. Reports Q1 Fiscal 2026 Financial Results

Earnings